Is there still place for VAD as primary treatment for patients with multiple myeloma who are candidates for high-dose therapy?

Leuk Lymphoma. 2006 Nov;47(11):2271-2. doi: 10.1080/10428190600908620.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Dexamethasone / therapeutic use
  • Doxorubicin / therapeutic use
  • Humans
  • Multiple Myeloma / drug therapy*
  • Vincristine / therapeutic use

Substances

  • Vincristine
  • Dexamethasone
  • Doxorubicin

Supplementary concepts

  • VAD I protocol